Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama 279: 1200–1205
Pirmohamed M, James S, Meakin S, et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj 329: 15–19
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4: e4439
Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296: 1858–1866
Gandhi TK, Weingart SN, Borus J, et al (2003) Adverse drug events in ambulatory care. N Engl J Med 348: 1556–1564
Moore TJ, Cohen MR, Furberg CD (2007) Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch Intern Med 167: 1752–1759
Ferner RE, Aronson JK (2010) EIDOS: a mechanistic classification of adverse drug effects. Drug Saf 33: 15–23
Aronson JK, Ferner RE (2003) Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 327: 1222–1225
Agrawal A, Aronson JK, Britten N, et al (2009) Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol 67: 592–598
Fokter N, Mozina M, Brvar M (2010) Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments. Wien Klin Wochenschr 122: 81–88
Spencer FA, Lessard D, Yarzebski J, Gore JM, Goldberg RJ (2005) Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J 150: 838–844
Floyd KC, Yarzebski J, Spencer FA, et al (2009) A 30-year perspective (1975–2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes 2: 88–95
McKinnon JE, Mellors JW, Swindells S (2009) Simplification strategies to reduce antiretroviral drug exposure: progress and prospects. Antivir Ther 14: 1–12
Egger SS, Ratz Bravo AE, Hess L, Schlienger RG, Krahenbuhl S (2007) Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging 24: 429–440
Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2: 79–87
Pitt B, Zannad F, Remme WJ, et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717
Juurlink DN, Mamdani MM, Lee DS, et al (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543–551
McMurray JJ, O'Meara E (2004) Treatment of heart failure with spironolactone – trial and tribulations. N Engl J Med 351: 526–528
Lau HS, Florax C, Porsius AJ, De Boer A (2000) The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 49: 597–603
Kaushal R, Shojania KG, Bates DW (2003) Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 163: 1409–1416
Constable S, Ham A, Pirmohamed M (2007) Herbal medicines and acute medical emergency admissions to hospital. Br J Clin Pharmaco. 63: 247–248
Bellosta S, Paoletti R, Corsini A (2004) Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 109: III50–III57
Seidling HM, Storch CH, Bertsche T, et al (2009) Successful strategy to improve the specificity of electronic statin-drug interaction alerts. Eur J Clin Pharmacol 65: 1149–1157
Pirmohamed M, Ferner RE (2003) Monitoring drug treatment – criteria used for screening tests should apply to monitoring. Br Med J 327: 1179–1181
Norgard NB, Mathews KD, Wall GC (2009) Drug-drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother 43: 1266–1274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pirmohamed, M. Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff. Wien Klin Wochenschr 122, 62–64 (2010). https://doi.org/10.1007/s00508-010-1309-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-010-1309-1